Joe Abdo retweeted
To commemorate his 930th career goal, 9:30 Club in Washington, DC, has presented Washington Capitals star Alexander Ovechkin a Golden Ticket granting him access to any 9:30 Club show for life.
Joe Abdo retweeted
Research by @NNezami1, @coffman_kelley, Jayne Green, @joe_abdo, Coleman Smith, Arul M. Thomas, @AmolRangnekar, Kathleen M. Nilles, Rachel L. Redfield, @DrKohli, Bahman Afsari, Alexander Kroemer, @RuthHe12, @ReetuMukherjiMD #ASCO26. @LombardiCancer @MedStarGUH. Learn more: asco.org/abstracts-presentat…
Joe Abdo retweeted
rewriting Wild history in record time
congratulations, Kirill
#mnwild | @StarTribune
Joe Abdo retweeted
@OxBioDynamics' @EpiSwitchCiRT strongly impacts #immunotherapy #CancerTreatment decisions:
✅Influenced 61% of cases
✅Results closely match outcomes
✅Peer-reviewed interim results of #PROWES trial
🔗mycirt.co/pws
#OBD @Keytruda @Tecentriq @Imfinzi @Opdivo @Bavencio
Honored to serve as first author on a paper published today in Cancers. Grateful for our clinical collaborators and, most of all, the patients whose participation continues to drive precision oncology forward.
mdpi.com/2072-6694/17/17/290…
My cousin is still on an all time run!!
THE JIMMY ABDO SHOW CONTINUES 🔥
The DIII golfer representing @GustieGolf will play in the quarterfinals at the U.S. Amateur.
My cousin Jimmy let’s go!!
The No. 4292 amateur in the world is moving on ‼️
Jimmy Abdo — a sophomore at Gustavus Adolphus College (@GustieGolf) — wins 1 up with this par save on 18.
Joe Abdo retweeted
NCAA Tournament Wins over the Last 5 Years
Louisville- 0
Kentucky- 1
Syracuse- 2
Indiana- 2
Michigan St- 4
Ryan Kalkbrenner- 9
Excited to announce I served as the Senior Author of a peer-reviewed article on an underpublicized oncology epidemic and potential molecular diagnostic solutions. I'd like to thank my coauthors from Georgetown University Medical Center and AstraZeneca. mdpi.com/2072-6694/17/6/1013
Joe Abdo retweeted
Bupa members across the UK with a concerning #PSA level can now access the EpiSwitch® PSE test that is setting a new benchmark in accurate #prostatecancer detection test.
#OBD @94percent_com #MensHealth @BupaUK
We’re excited to expand our partnership with @BupaUK, the UK’s leading health insurer, serving over 3 million people. Bupa UK members with a raised PSA level and no additional high risk factors or symptoms will now be covered for EpiSwitch® PSE, an innovative blood test that detects the presence or absence of prostate cancer with 94% accuracy.
As prostate cancer is now the most common cancer in men in the UK, early and accurate detection is critical. The EpiSwitch PSE test helps reduce unnecessary referrals for MRI scans and biopsies, saving both time and resources.
The EpiSwitch PSE test empowers healthcare professionals and patients to make informed decisions together, ensuring timely and appropriate care that can ultimately improve outcomes and save lives.
Learn more: obdx.co/834.
#OBD #ProstateCancer #EpiSwitchPSE @94percent_com
Joe Abdo retweeted
Thanks to former UK Prime Minister Rishi Sunak for visiting Oxford BioDynamics to unveil his role as a Prostate Cancer Research ambassador. Mr. Sunak praised OBD for our work on the world-leading EpiSwitch® PSE blood test, met patients, and called for a targeted national screening program to detect #ProstateCancer early and save lives.
@PCR_News @94percent_com @RishiSunak #OBD #EpiSwitchPSE #EarlyDetectionSavesLives
Joe Abdo retweeted
At the Liquid Biopsy for Precision Oncology Summit, Ryan Mathis, MD, highlighted how EpiSwitch® 3D genomic #biomarkers are unlocking new possibilities in early cancer detection, prognosis, and treatment response prediction. Oxford BioDynamics is proud to support innovation in #LiquidBiopsy and #PrecisionOncology.
#PrecisionMedicine #Genomics #OBD @HansonWade



























